Abstract
The purpose of the current study is to evaluate the effectiveness of Hypericin Photodynamic therapy (PDT) alone or associated with BCG immunization as an oncotherapy in Swiss mice. For this purpose, 90 mature male swiss mice were chosen and equally divided into 5 comparable groups. The first, was a negative control group, the second was hypericin contol group and the third was tumor control group. The forth and fifth groups were the treated groups with Hypericin-PDT and BCG/ Hypericin – PDT, respectively. They were subjected to the treating regimen as follows: a dose of 5 mg/kg body weight of an aqueous ethanolic Hypericin solution was injected by both intra-peritoneal (i.p.) and intratumoral (i.t.) injections, followed 2 hours later by exposure to non-coherent light (590 nm) for 5 minutes in each session. Mice received 5 sessions / week for 6 weeks. Both treatments resulted in pronounced degeneration and necrosis of the neoplastic cells with replacement of tumor masses by fibrous connective tissue. The curative rate was enhanced when Hypericin-PDT was accompanied by BCG as an immuno-stimulating agent. From the pathological pictures, it can be concluded that Hypericin-PDT is an effective treatment for superficial neoplasms. BCG administration, as a non-specific immuno-stimulant, enhances the therapeutic effect of Hypericin -PDT.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.